BFCFSI
TENX icon

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Tenax Therapeutics TENX Stock Holding History

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$7 – 2456
2025
Q1 		$7 Buy
+1
New +$6 ﹤0.01% 2250
2024
Q4 		– Sell
-1
Closed -$3 – 2239
2024
Q3 		$3 Buy
+1
New +$4 ﹤0.01% 2168

Other funds holding TENX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Integral Health Asset Management
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s TENX Position: Q2 2025 in Review

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold out of Tenax Therapeutics (TENX) in Q2 2025, closing a stake of 1 share — an estimated $7 sold.

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in TENX in Q3 2024 and held it in 2 quarters. The position peaked at $7 in Q1 2025. 27 funds tracked by Wall St. Rank hold TENX as of Q2 2025.

  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. reported no remaining Tenax Therapeutics position as of Q2 2025 after selling out during the quarter.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold 1 Tenax Therapeutics share in Q2 2025, an estimated $7.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in Tenax Therapeutics in Q3 2024 and held it in 2 quarters.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s Tenax Therapeutics position peaked at $7 in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2025.

Based on BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s 13F filing for Q2 2025, filed 30 Oct 2026.